For example, a consortium of research groups called the London Project to Cure Blindness aims to test RPE transplants from embryonic stem cells
in patients with macular degeneration this year.
In 1997, the mainstays of therapy
for patients with macular degeneration include daily monitoring of the integrity of their central vision (usually by viewing a simple printed grid) as well as periodic visits to their eye doctor.
In approximately 10 percent
of patients with macular degeneration, the injury to the retinal pigment epithelium stimulates the choroidal blood vessels to grow up into the RPE and retina — seemingly in an attempt to heal the defects in these layers.
This high - magnification image shows a retinal hemorrhage in
a patient with macular degeneration.
«We found that intensive doses of statins carry the potential for clearing up the lipid debris that can lead to vision impairment in a subset of
patients with macular degeneration,» said Joan W. Miller, M.D., the Henry Willard Williams Professor and Chair of Ophthalmology at Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital.
In 2011 NYSCF awarded Dr. Pete Coffey the inaugural NYSCF — Robertson Stem Cell Prize for his pioneering work bringing stem cell therapies to
patients with macular degeneration...